SCHEMBL24368554

SCHEMBL24368554

c1ccc2cc(-c3ccc(N(c4ccc(-c5ccc6ccccc6c5)cc4)c4ccc(-c5cc6cc7ccccc7cc6s5)cc4)cc3)ccc2c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 3/20 0.43
▸ ESR1 P03372 5/20 0.42
▸ ESR2 Q92731 5/20 0.42
▸ HSD17B1 P14061 2/20 0.39
▸ HSD17B2 P37059 2/20 0.39
▸ CA1 P00915 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ CA9 Q16790 2/20 0.38
▸ ALOX5 P09917 1/20 0.37
▸ LPL P06858 1/20 0.36
▸ LIPG Q9Y5X9 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ S1PR4 O95977 1/20 0.35
▸ S1PR5 Q9H228 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24369005 0.97 ESR1 (0.47) APPESR1ESR2HSD17B1HSD17B2
SCHEMBL24368563 0.97 ESR1 (0.47) APPESR1ESR2HSD17B1HSD17B2
SCHEMBL24369003 0.92 APP (0.49) APPESR1ESR2HSD17B1HSD17B2
SCHEMBL24369001 0.91 ESR1 (0.47) APPESR1ESR2HSD17B1HSD17B2
SCHEMBL24368555 0.91 ESR1 (0.47) APPESR1ESR2HSD17B1HSD17B2
SCHEMBL24369006 0.91 ESR1 (0.47) APPESR1ESR2HSD17B1HSD17B2
SCHEMBL24368958 0.91 ESR1 (0.47) APPESR1ESR2HSD17B1HSD17B2
SCHEMBL24368463 0.90 APP (0.55) APPESR1ESR2HSD17B1HSD17B2
SCHEMBL24368397 0.90 APP (0.55) APPESR1ESR2HSD17B1HSD17B2
SCHEMBL24368637 0.90 APP (0.55) APPESR1ESR2HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127277-A1 ORGANIC COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DIODE COMPRISING THE SAME DONGJIN SEMICHEM CO., LTD. (KR) 2022-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127277-A1 ORGANIC COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DIODE COMPRISING THE SAME CAPG, CAPZA1, OCIAD1 APP 3924/4885ESR1 2033/4885ESR2 2183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback